The Motley Fool Previous Page

EU Approval? Fat Chance!

Brian Orelli, Ph.D.
September 21, 2012

In general, there's a little lower threshold for getting a drug approved by the European Medicines Agency than there is for approval by the Food and Drug Administration. Merck's (NYSE: MRK  ) Cordaptive, Cell Therapeutics' (Nasdaq: CTIC  ) Pixuvri, and InterMune's (Nasdaq: ITMN  ) Esbriet were all approved in Europe, but were -- at least initially -- rejected in the U.S.